Mark Pruzanski, President & CEO at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 50,000 shares at $100.00 ($5.0M) on 2019-11-25, disclosed to the SEC on 2019-11-27.
Open-market sale of $5.0M ICPT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.00 | 14,563 | $1.5M | 29.1% |
| 2 | $100.00 | 35,437 | $3.5M | 70.9% |
| Total | $100.00 avg | 50,000 | $5.0M | 100% |
| Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | BUY | 2018-04-09 | $500K | — | Filing → |
| ICPT | SELL | 2017-10-04 | $180K | — | Filing → |